Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
100,950,119
-
Total 13F shares
-
36,247,262
-
Share change
-
-9,696,156
-
Total reported value
-
$19,192,190
-
Put/Call ratio
-
33%
-
Price per share
-
$0.53
-
Number of holders
-
64
-
Value change
-
-$4,584,403
-
Number of buys
-
22
-
Number of sells
-
35
Institutional Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q4 2024
As of 31 Dec 2024,
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) was held by
64 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,247,262 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, PRIMECAP MANAGEMENT CO/CA/, ACADIAN ASSET MANAGEMENT LLC, BlackRock, Inc., 683 Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, MARSHALL WACE, LLP, GEODE CAPITAL MANAGEMENT, LLC, and TWO SIGMA ADVISERS, LP.
This page lists
65
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.